in_the_media

Philadelphia Inquirer - November 12, 2010

Media Outlet: 

Philadelphia Inquirer



Pharmaceutical companies once relied on their own research-and-development divisions to identify and deliver blockbuster medications. In recent years, that path has been unproductive. Albert Wertheimer of the School of Pharmacy said the industry now believes that R&D alone isn't the answer. "The takeaway message is you are better off buying the products from smaller companies or foreign companies that don't have marketing arms in the U.S.," he said.